J. THORNTON to Drug Prescriptions
This is a "connection" page, showing publications J. THORNTON has written about Drug Prescriptions.
Connection Strength
0.920
-
Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339.
Score: 0.194
-
Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. J Pain Palliat Care Pharmacother. 2022 Jun; 36(2):103-111.
Score: 0.169
-
Association of cash payment with intensity of opioid prescriptions. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1224-1231.e5.
Score: 0.165
-
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas. J Addict Med. 2020 12; 14(6):e372-e374.
Score: 0.152
-
Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008.
Score: 0.147
-
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
Score: 0.047
-
Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2023 Jul; 169(1):176-184.
Score: 0.044